nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A community oncologist comments
|
Bosserman, Linda D. |
|
2004 |
1 |
2 |
p. 87-91 5 p. |
artikel |
2 |
Bortezomib in multiple myeloma
|
|
|
2004 |
1 |
2 |
p. 77-79 3 p. |
artikel |
3 |
Cancer Care Act of 2004 introduced in the Senate
|
|
|
2004 |
1 |
2 |
p. 124- 1 p. |
artikel |
4 |
Developments in antiemetic therapy
|
|
|
2004 |
1 |
2 |
p. 79-81 3 p. |
artikel |
5 |
Experts predict more pressure to standardize, measure quality of cancer care
|
Kelly, Janis |
|
2004 |
1 |
2 |
p. 103-104 2 p. |
artikel |
6 |
Extramammary Paget's disease
|
Rao, Venkatesh R. |
|
2004 |
1 |
2 |
p. 109-114 6 p. |
artikel |
7 |
Fitting bortezomib into clinical practice
|
Vescio, Robert A. |
|
2004 |
1 |
2 |
p. 78-79 2 p. |
artikel |
8 |
HMO profits soar, healthcare falters
|
|
|
2004 |
1 |
2 |
p. 119-120 2 p. |
artikel |
9 |
How we do it: acute antiemetic treatment
|
Maxwell, Cathy |
|
2004 |
1 |
2 |
p. 82- 1 p. |
artikel |
10 |
Lessons learned
|
Marshall, John L. |
|
2004 |
1 |
2 |
p. 114- 1 p. |
artikel |
11 |
Oncology and hospice care
|
Weissman, David E. |
|
2004 |
1 |
2 |
p. 85-91 7 p. |
artikel |
12 |
PDA applications: drug reference guides
|
|
|
2004 |
1 |
2 |
p. 105-107 3 p. |
artikel |
13 |
Shortcomings and flaws in Medicare coding that affect oncologist practices
|
|
|
2004 |
1 |
2 |
p. 123-124 2 p. |
artikel |
14 |
The NCCN guidelines: how do they relate to community oncology practice?
|
Powers, Ellen Okin |
|
2004 |
1 |
2 |
p. 98-102 5 p. |
artikel |
15 |
Transitioning patients to palliative care
|
Schwartzberg, Lee S. |
|
2004 |
1 |
2 |
p. 75-76 2 p. |
artikel |
16 |
Why Medicare expenditures for cancer drugs are under fire
|
Okon, Ted |
|
2004 |
1 |
2 |
p. 123- 1 p. |
artikel |
17 |
Will partial breast irradiation be a cost-effective alternative to whole breast irradiation in the treatment of early-stage breast cancer?
|
Konski, Andre A. |
|
2004 |
1 |
2 |
p. 93-97 5 p. |
artikel |